The Enterprise Value as of September 2024 (TTM) for ProKidney Corp. (PROK) is 484.49M

According to ProKidney Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 484.49M. This represents a change of 1.24% compared to the average of 36.22M of the last 4 quarters.

ProKidney Corp. (PROK) Historical Enterprise Value (quarterly & annually)

How has PROK Enterprise Value performed in the past?

The mean historical Enterprise Value of ProKidney Corp. over the last ten years is 895.45M. The current 484.49M Enterprise Value has changed 5.31% with respect to the historical average. Over the past ten years (40 quarters), PROK's Enterprise Value was at its highest in in the June 2022 quarter at 627.44M. The Enterprise Value was at its lowest in in the December 2022 quarter at -65687015.34.

ProKidney Corp. (PROK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ProKidney Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ProKidney Corp. (PROK) Average Enterprise Value

How has PROK Enterprise Value performed in the past?

The current Enterprise Value of ProKidney Corp. (PROK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ProKidney Corp. (PROK) Enterprise Value vs. Peers

How is PROK’s Enterprise Value compared to its peers?

ProKidney Corp.’s Enterprise Value is less than Relay Therapeutics, Inc. (1.19B), less than Stoke Therapeutics, Inc. (609.36M), less than Pliant Therapeutics, Inc. (747.15M), greater than Black Diamond Therapeutics, Inc. (261.06M), less than Arvinas, Inc. (1.60B), less than Arcellx, Inc. (4.57B), greater than Ventyx Biosciences, Inc. (137.83M), less than Immunocore Holdings plc (1.68B), less than Vaxcyte, Inc. (13.77B), less than DICE Therapeutics, Inc. (2.21B), greater than Third Harmonic Bio, Inc. (353.63M), greater than PMV Pharmaceuticals, Inc. (41.95M), less than Edgewise Therapeutics, Inc. (2.73B), greater than Enochian Biosciences, Inc. (87.47M), less than Revolution Medicines, Inc. (7.53B), less than Kura Oncology, Inc. (1.59B), less than Protagonist Therapeutics, Inc. (2.36B), less than Merus N.V. (2.85B), less than Replimune Group, Inc. (691.54M), less than Cerevel Therapeutics Holdings, Inc. (8.24B), greater than Monte Rosa Therapeutics, Inc. (319.09M), less than Erasca, Inc. (720.20M), greater than Lyell Immunopharma, Inc. (326.16M),

Build a custom stock screener for ProKidney Corp. (PROK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProKidney Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProKidney Corp. (PROK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProKidney Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.